BGF World Healthscience: Qual. Rating Issued

BlackRock World Healthscience is a worthy option for investors seeking healthcare exposure.

Mark Laidlaw 17 July, 2009 | 3:18PM
Facebook Twitter LinkedIn
We have published a new Morningstar Qualitative Rating and Research Report for BlackRock Global Funds - World Healthscience.

"This fund benefits greatly from experienced leadership in the shape of manager, Robert Hodgson. He comes across as one of the better managers we have seen in

the healthcare sector and has a wealth of experience, with over 25 years specialising in this field and the last 12 with the firm (coming from the MLIM side prior to the 2006 merger). He displays a deep knowledge of the sector and a keen ability to understand and interpret...

The full four page pdf report can be accessed here. It is free to users of Morningstar.co.uk.

The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell a security or securities noted within nor should it be viewed as a communication intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. The information contained within should not be a person's sole basis for making an investment decision. Please contact your financial professional before making an investment decision.

Facebook Twitter LinkedIn

Securities Mentioned in Article

Security NamePriceChange (%)Morningstar
Rating
BGF World Healthscience A268.23 USD0.22Rating

About Author

Mark Laidlaw  Mark Laidlaw is a senior analyst, manager research for Morningstar.

© Copyright 2024 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures